Bacterial cultures, rapid strep test, and antibiotic treatment in infected hard-to-heal ulcers in primary care

References

• Öien RF, Håkansson A, Ovhed I, Hansen BU. Wound management for 287 patients with chronic leg ulcers demands 12 full-time nurses. Leg ulcer epidemiology and care in a well-defined population in Southern Sweden. Scand J Prim Health Care 2000;18:220–5.
   PubMed Web of Science ®Google Scholar
• Wiström J, Lindholm C, Melhus A, Lundgren C, Hansson C. Infections and treatment in chronic leg ulcers: The use of antibiotics is too excessive, restrictive prescription is recommended [in Swedish]. Lakartidningen. 1999;6:96:42–6.
   Google Scholar
• André M, Eriksson M, Odenholt I. Treatment of patients with skin and soft tissue infections: Results from the STRAMA survey of diagnoses and prescriptions among general practitioners. Lakartidningen 2006;103:3165–7. [in Swedish].
   PubMedGoogle Scholar
• European Wound Management Association (EWMA) Position document: Management of wound infection. London: MEP; 2006.
   Google Scholar
• Cutting KF, White RJ. Criteria for identifying wound infection – revisited. Ostomy Wound Manage 2005;51:28–34.
   PubMedGoogle Scholar
• Petursson P. GPs’ reasons for “non-pharmacological” prescribing of antibiotics: A phenomenological study. Scand J Prim Health Care 2005;23:120–5.
   PubMed Web of Science ®Google Scholar
• Lindholm C, Bjellerup M, Christensen OB, Zederfeldt B. Quality of life in chronic leg ulcer patients: An assessment according to the Nottingham Health Profile. Acta Derm Venereol 1993;73:440–3.
   PubMedGoogle Scholar
• Anon. Evidence-based prescribing of advanced wound dressings for chronic wounds in primary care. MeRec Bulletin 2010;1:1–7.
   Google Scholar
• Hansson C, Hoborn J, Möller A, Swanbeck G. The microbial flora in venous leg ulcers without clinical signs of infection: Repeated culture using a validated standardised microbiological technique. Acta Derm Venereol 1995;75: 24–30.
   PubMedGoogle Scholar
• Brook I, Frazier EH. Aerobic and anaerobic microbiology of chronic venous ulcers. Int J Dermatol 1998;37:426–8.
   PubMed Web of Science ®Google Scholar
• Körber A, Schmid EN, Buer J, Klode J, Schadendorf D, Dissemond J. Bacterial colonization of chronic leg ulcers: Current results compared with data 5 years ago in a specialized dermatology department. J Eur Acad Dermatol Venereol. 2010;24:1017–25. Epub 2010 Mar 4.
   PubMed Web of Science ®Google Scholar
• Recommendation from the Medical Products Agency – Sweden. Farmakologisk behandling av bakteriella hud- och mjukdelsinfektioner- ny rekommendation [Pharmacological treatment of bacterial skin and soft tissue infections]. 2009;20(5). Available from: http://www.lakemedelsverket.se/ [in Swedish].
   Google Scholar
• Eriksson B, Jorup-Rönström C, Karkkonen K, Sjöblom AC, Holm SE. Erysipelas: Clinical and bacteriologic spectrum and serological aspects. Clin Infec Dis 1996; 23:1091–8.
   PubMed Web of Science ®Google Scholar
• Bartholomeeusen S, Vandenbroucke J, Truyers C, Buntinx F. Epidemiology and comorbidity of erysipelas in primary care. Dermatology 2007;215:118–22.
   PubMedGoogle Scholar
• Öien RF. RUT (Register of Ulcer Treatment) – a winning concept for both patients and the health care sector. EWMA J 2009;9:41–4.
   Google Scholar
• Llor C, Hernández S, Sierra N, Moragas A, Hernández M, Bayona C. Association between use of rapid antigen detection tests and adherence to antibiotics in suspected streptococcal pharyngitis. Scand J Prim Health Care 2010; 28:12–17.
   PubMed Web of Science ®Google Scholar
• Moffatt CJ, Franks PJ, Oldroyd M, Bosanquet N, Brown P, Greenhalgh RM, et al.Community clinics for leg ulcers and impact on healing. BMJ 1992;305:1389–92.
   PubMedGoogle Scholar
• Forssgren A, Fransson I, Nelzén O. Leg ulcer point prevalence can be decreased by broad-scale intervention: A follow-up cross-sectional study of a defined geographical population. Acta Derm Venereol 2008;88:252–6.
   PubMedGoogle Scholar
• Corey GR, Wilcox MH, Talbot GH, Thye D, Friedland D, Baculik T. CANVAS 1: The first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. J Antimicrob Chemother 2010;65(Suppl 4): iv41–51. doi:10.1093/jac/dkq254
   Google Scholar
• Cohen-Poradosu R, Jaffe J, Lavi D, Grisariu-Greenzaid S, Nir-Paz R, Valinsky L, . Group G streptococcal bacteremia in Jerusalem. Emerg Infect Dis 2004;10:1455–60.
   PubMedGoogle Scholar
• Skogberg K, Simonen H, Renkonen O-V, Valtonen VV. Beta-haemolytic group A, B, C and G streptococcal septicaemia: A clinical study. Scand J Infect Dis 1988;20:119–25.
   PubMed Web of Science ®Google Scholar
• Dobie D, Gray J. Fusidic acid resistance in Staphylococcus aureus. Arch Dis Child 2004;89:74–7.
   PubMed Web of Science ®Google Scholar
• Bangert S, Levy M, Hebert AA. Bacterial resistance and impetigo treatment trends: A review. Pediatr Dermatol 2012;29:243–48.
   PubMed Web of Science ®Google Scholar
• Gjelstad S, Dalen I, Lindbaek M. GPs’ antibiotic prescription patterns for respiratory tract infections: Still room for improvement. Scand J Prim Health Care 2009;27: 208–15.
   PubMed Web of Science ®Google Scholar
• Patel M. Community-associated methicillin-resistant Staphylococcus aureus infections: Epidemiology, recognition and management. Drugs 2009;69:693–716. doi: 10.2165/00003495-200969060-00004.
   PubMed Web of Science ®Google Scholar
• Broyles LN, Van Beneden C, Beall B, Facklam R, Shewmaker PL, Malpiedi P. et al. Population-based study of invasive disease due to beta-hemolytic streptococci of groups other than A and B. Clin Infect Dis 2009;48:706–12.
   PubMed Web of Science ®Google Scholar